Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

OBJECTIVES To determine the prevalence of antibodies to hepatitis C virus (HCV) in female sexual partners of multitransfused men with hemophilia and to compare the frequency of transmission of HCV and human immunodeficiency virus (HIV). STUDY DESIGN Cross-sectional measurement of HCV and HIV antibodies. SETTING Ten hemophilia treatment centers. PATIENTS A total of 234 female sexual partners of 231 multitransfused men with hemophilia. MEASUREMENTS AND MAIN RESULTS The prevalence of antibodies to HCV (anti-HCV) among female sexual partners of HCV-positive men was 5 of 194 (2.6%). Anti-HIV prevalence among female sexual partners of HIV-positive men was 25 of 196 (12.8%). Five (3%) of the 164 female sexual partners of HIV-positive/HCV-positive men were infected with HCV compared with none of the 30 female sexual partners of HIV-negative/HCV-positive men. Twenty-one (13%) of the 164 female sexual partners of HIV-positive/HCV-positive men were infected with HIV compared with 4 (13%) of 32 female sexual partners of HIV-positive/HCV-indeterminate men. The co-infected men were five times more likely to transmit both viruses than would be expected by chance (P = 0.01). When a single virus was transmitted to a female sexual partner, it was more often HIV than HCV (18 of 164 compared with 2 of 164, P = 0.001; odds ratio, 8.5; 95% Cl, 2.2 to 33.1). CONCLUSIONS The higher prevalence of HCV in female sexual partners of men with hemophilia than in blood donor and other low-risk groups suggests that there is a low level of sexual transmission. Male to female sexual transmission of HCV is less efficient than that of HIV. The frequency of HCV transmission to sexual partners is five times higher when HIV is also transmitted, suggesting that HIV may be a cofactor for the sexual transmission of HCV.

[1]  H. Margolis,et al.  Public health service interagency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C , 1991 .

[2]  M. Houghton,et al.  Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay , 1991, The Lancet.

[3]  R. Biggar,et al.  Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men. , 1990, BMJ.

[4]  G. Zuccotti,et al.  Maternal-infant transmission of hepatitis C virus and HIV infections: a possible interaction , 1990, The Lancet.

[5]  M. Houghton,et al.  Hepatitis C antibody and chronic liver disease in haemophilia , 1990, The Lancet.

[6]  G. Ippolito,et al.  Zidovudine in post-exposure prophylaxis of health-care workers , 1990, The Lancet.

[7]  J. Hoofnagle,et al.  Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. , 1990, Annals of internal medicine.

[8]  P. Mannucci,et al.  High prevalence of antibody to hepatitis C virus in multitransfused hemophiliacs with normal transaminase levels. , 1990, Annals of internal medicine.

[9]  S. Hadler,et al.  Heterosexual transmission of hepatitis B virus in Belle Glade, Florida. Belle Glade Study Group. , 1990, The Journal of infectious diseases.

[10]  J. Rosenblatt,et al.  Detection of hepatitis C viral sequences in non-A, non-B hepatitis , 1990, The Lancet.

[11]  R. Purcell,et al.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. , 1989, The New England journal of medicine.

[12]  M. Houghton,et al.  PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA , 1989, The Lancet.

[13]  J. Bruix,et al.  PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN SPANISH PATIENTS WITH HEPATOCELLULAR CARCINOMA AND HEPATIC CIRRHOSIS , 1989, The Lancet.

[14]  H. Margolis,et al.  Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. , 1989, JAMA.

[15]  M. Buti,et al.  HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN , 1989, The Lancet.

[16]  M. Houghton,et al.  ANTI-HEPATITIS C ANTIBODIES AND NON-A, NON-B POST-TRANSFUSION HEPATITIS IN THE NETHERLANDS , 1989, The Lancet.

[17]  Jules L. Dienstag,et al.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis , 1989 .

[18]  M. Houghton,et al.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.

[19]  K. Castro,et al.  Transmission of HIV in Belle Glade, Florida: lessons for other communities in the United States. , 1988, Science.

[20]  L. Bianchi,et al.  Histologic Patterns of Liver Disease in Hemophiliacs, with Special Reference to Morphologic Characteristics of Non-A, Non-B Hepatitis , 1987, Seminars in liver disease.

[21]  J. Goedert,et al.  Heterosexual transmission of human immunodeficiency virus: association with severe depletion of T-helper lymphocytes in men with hemophilia. , 1987, AIDS research and human retroviruses.

[22]  J. Levy,et al.  AIDS retrovirus antibodies in hemophiliacs treated with factor VIII or factor IX concentrates, cryoprecipitate, or fresh frozen plasma: prevalence, seroconversion rate, and clinical correlations. , 1986, Blood.

[23]  L. Bianchi,et al.  A study of liver biopsies and liver disease among hemophiliacs. , 1985, Blood.

[24]  J. Goedert,et al.  Development and early natural history of HTLV-III antibodies in persons with hemophilia. , 1985, JAMA.

[25]  B. Evatt,et al.  Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic. , 1985, The New England journal of medicine.

[26]  P. Levine,et al.  Aetiology of AIDS—antibodies to human T-cell leukaemia virus (type III) in haemophiliacs , 1984, Nature.

[27]  J. Dienstag.  Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features , 1983 .

[28]  R. Purcell,et al.  CLINICAL AND SEROLOGICAL ANALYSIS OF TRANSFUSION-ASSOCIATED HEPATITIS , 1975, The Lancet.